The Swedish CArdioPulmonary bioImage Study – SCAPIS – is a nationwide, open-access, population-based cohort for the study of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).

The aim is to predict and prevent cardiovascular and pulmonary disease. A total of 30,154 men and women in Sweden, from 50 to 64 years old, have been recruited and investigated with detailed imaging and functional analyses of the cardiovascular and pulmonary systems. The first public release of data was on March 17, 2021. All researchers based in Sweden, or international researchers in collaboration with an applicant based in Sweden, are welcome to apply for data.

SCAPIS 2 – re-examination
A re-examination of the study participants in SCAPIS is currently being planned. The purpose of SCAPIS 2 is to re-examine half of these study participants, a total of 15,000, at all sites, which will provide a unique opportunity to follow the participants' health. The study will start in January 2024.

  • Två sjuksystrar granskar röntgenbilder

    Data access

    Access to SCAPIS is granted on a case by case basis

    Apply for data access
  • Tre forskare i forskningslaboratorium

    Research

    Research projects that have been granted SCAPIS data are presented here continuously

    See granted projects
  • Sköterska och patient vid en spirometer

    Publications

    Published articles based on SCAPIS data

    See publications
Forskares händer i ett lab

SCAPIS database news April 2023

It is now possible to apply for new data from extended laboratory analyses, covering biomarkers for a range of disease and health states for the entire SCAPIS cohort. In addition, SNPs for SCAPIS genetics data can now be downloaded.

For more information

The novelty and significant contribution of SCAPIS is that it combines size with extensive phenotyping. The aim of SCAPIS is to predict and prevent CVD and CPD. The goal is to further develop individualized treatment and improve health care by building this research resource.

SCAPIS is a unique study made possible through a collaborative effort between six Swedish universities (Uppsala University, Umeå University, Linköping University, Lund University, University of Gothenburg and Karolinska Institutet) and university hospitals (Uppsala University Hospital, University Hospital of Umeå, Linköping University Hospital, Skåne University Hospital, Sahlgrenska University Hospital and Karolinska University Hospital).

The main funder of SCAPIS is the Swedish Heart-Lung Foundation, with considerable support from the Knut and Alice Wallenberg Foundation, Vinnova, The Swedish Research Council and the participating Universities and University Hospitals.

Newsletter about the SCAPIS study

Get news from the SCAPIS study. Sign up by registering your email address.

By proceeding, I consent to my personal data being processed in accordance with Hjärt-lungfonden's privacy policy

Logotyp SCAPIS

Data protection

Cookie usage

Logotyp Göteborgs universitet
Logotyp Karolinska institutet
Logotyp Linköpings universitet
Logotyp Lunds universitet
Logotyp Uppsala universitet
Logotyp Umeå universitet
Logotyp Norrlands universitetssjukhus
Logotyp Universitetssjukhuset i Linköping
Logotyp Skånes universitetssjukhus
Logotyp Västra Götalandsregionen
Logotyp Karolinska universitetssjukhuset
Logotyp Akademiska sjukhuset
Logo Swedish Heart-Lung Foundation as main funder of SCAPIS